$11.75 Billion: How Sun Pharma’s Biggest-Ever Deal Rewrites Indian Pharma’s Global Ambitions
THE BIGGEST CHEQUE AN INDIAN DRUGMAKER HAS EVER WRITTEN Indian pharmaceutical companies have spent the better part of two decades quietly building global manufacturing reach, mostly through incremental capacity expansion and a steady drumbeat of mid-sized acquisitions. Sun Pharmaceutical Industries just broke entirely from that pattern. The company announced it will acquire New York-listed Organon…